ATE203997T1 - Antiwachstumwirksame proteine aus oozyten von rana pipiens - Google Patents

Antiwachstumwirksame proteine aus oozyten von rana pipiens

Info

Publication number
ATE203997T1
ATE203997T1 AT96916935T AT96916935T ATE203997T1 AT E203997 T1 ATE203997 T1 AT E203997T1 AT 96916935 T AT96916935 T AT 96916935T AT 96916935 T AT96916935 T AT 96916935T AT E203997 T1 ATE203997 T1 AT E203997T1
Authority
AT
Austria
Prior art keywords
rana pipiens
extract
subjected
growth proteins
oocytes
Prior art date
Application number
AT96916935T
Other languages
English (en)
Inventor
Wojciech J Ardelt
Original Assignee
Alfacell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfacell Corp filed Critical Alfacell Corp
Application granted granted Critical
Publication of ATE203997T1 publication Critical patent/ATE203997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96916935T 1995-06-06 1996-06-03 Antiwachstumwirksame proteine aus oozyten von rana pipiens ATE203997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/467,955 US5728805A (en) 1988-04-06 1995-06-06 Pharmaceuticals and method for making them
PCT/US1996/008304 WO1996039428A1 (en) 1995-06-06 1996-06-03 Antitumor proteins from rana pipiens oocytes

Publications (1)

Publication Number Publication Date
ATE203997T1 true ATE203997T1 (de) 2001-08-15

Family

ID=23857833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916935T ATE203997T1 (de) 1995-06-06 1996-06-03 Antiwachstumwirksame proteine aus oozyten von rana pipiens

Country Status (7)

Country Link
US (1) US5728805A (de)
EP (1) EP0837878B1 (de)
JP (1) JP3779999B2 (de)
AT (1) ATE203997T1 (de)
AU (1) AU5964796A (de)
DE (1) DE69614390T2 (de)
WO (1) WO1996039428A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653104B2 (en) 1996-10-17 2003-11-25 Immunomedics, Inc. Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
HU221407B1 (hu) * 1997-03-28 2002-09-28 Gyula Magvasi Ektodermális eredetû szövetekben fellépõ tumoros burjánzást gátló hatóanyag és készítmény, valamint eljárás elõállításukra
ATE302217T1 (de) * 1997-05-02 2005-09-15 Us Gov Health & Human Serv Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
US6869604B1 (en) * 1998-03-27 2005-03-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Recombinant anti-tumor RNAse
US6239257B1 (en) * 1998-12-30 2001-05-29 Alfacell Corporation Family of proteins belonging to the pancreatic ribonuclease a superfamily
CA3061666C (en) 2014-03-28 2021-04-27 Tamir Biotechnology, Inc. Rnase for use in treating or preventing viral infections
US9919034B2 (en) 2014-03-28 2018-03-20 Tamir Biotechnology, Inc. Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
US10835598B2 (en) 2014-08-18 2020-11-17 Orgenesis Inc. Prophylactic protection against viral infections, particularly HIV
US9642794B2 (en) 2014-08-18 2017-05-09 Tamir Biotechnology, Inc. Antiviral pharmaceutical for topical administration
ES3068183T3 (en) * 2015-06-15 2026-05-28 Orgenesis Inc Pharmaceuticals for treatment of viral infections of the eye
KR102789464B1 (ko) 2015-09-25 2025-04-03 오코겐, 인크. 란피르나제 및/또는 암피나제를 사용하는 바이러스성 결막염의 치료
WO2017142807A1 (en) 2016-02-16 2017-08-24 Tamir Biotechnology, Inc. Treatment or prevention of zika virus infections by administration of a ribonuclease
US11331378B2 (en) 2016-07-26 2022-05-17 Orgenesis Inc. Prophylactic protection against viral infections
WO2018022774A1 (en) 2016-07-26 2018-02-01 Squiquera Luis Prophylactic protection against viral infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374061A (en) * 1981-07-27 1983-02-15 Center For Blood Research, Inc. Means and methods for purifying Clq, Clr and Cls
US4882421A (en) * 1982-09-23 1989-11-21 Alfacell Corporation Pharmaceutical for treating tumors and method for making it
US5595734A (en) * 1988-04-06 1997-01-21 Alfacell Corporation Compositions comprising ONCONASE (tm) and lovastatin
US5540925A (en) * 1988-04-06 1996-07-30 Alfacell Corporation Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)
US5529775A (en) * 1988-04-06 1996-06-25 Alfacell Corporation Compositions comprising ONCONASE(™) and cisplatin, melphalan, or doxorubicin HCl
US5559212A (en) * 1988-04-06 1996-09-24 Alfacell Corporation Frog embryo and egg-derived tumor cell anti-proliferation protein
DE69006741T2 (de) * 1989-11-13 1994-06-01 Alfacell Corp Reines protein und bioaktive pharmazeutische produkte.
DE69306118T2 (de) * 1992-07-30 1997-05-15 Alfacell Corp Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0837878B1 (de) 2001-08-08
JPH11507041A (ja) 1999-06-22
EP0837878A1 (de) 1998-04-29
DE69614390D1 (de) 2001-09-13
WO1996039428A1 (en) 1996-12-12
AU5964796A (en) 1996-12-24
DE69614390T2 (de) 2001-12-06
US5728805A (en) 1998-03-17
JP3779999B2 (ja) 2006-05-31

Similar Documents

Publication Publication Date Title
Kim et al. Purification and characterization of antioxidative peptides from bovine skin
Olden et al. Function of glycoprotein glycans
Lepage et al. Purification and characterization of the sea urchin embryo hatching enzyme
DE69614390D1 (de) Antiwachstumwirksame proteine aus oozyten von rana pipiens
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
McDevitt et al. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
DE69033700D1 (de) Il-11 aus säugetier
BR9911549A (pt) Processo de produção de fitase em levedura
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
DE69731463D1 (de) Rekombinante ribonuklease proteine
ATE98869T1 (de) Pharmazeutisches mittel fuer behandlung von menschlichem krebs und verfahren zu seiner herstellung.
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
MY104909A (en) Peptide compounds.
IL152406A0 (en) Anti-freeze proteins, their production and use
YU69691A (sh) Postupak za pripremu stranih proteina u streptomicetama
GB1174169A (en) Process for the manufacture of preparations rich in interferon
FI964186A0 (fi) Ei-liittävät gp350/220-variantit
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
PT782630E (pt) Gene da doenca poliquistica do rim
ATE103930T1 (de) Modifizierte proteine.
ATE101621T1 (de) Reines protein und bioaktive pharmazeutische produkte.
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
NZ335534A (en) Method of identifying potential pharmaceuticals from plant extracts

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0837878

Country of ref document: EP